Cargando…

Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis

The relationship between the cluster of differentiation 226 (CD226)/T cell Ig and ITIM domain (TIGIT) immune checkpoint and primary biliary cholangitis (PBC) pathogenesis is unknown. Herein, PBC patients (n = 42) showed significantly higher proportions of peripheral CD8(+) T and CD4(+) T cells expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Chuiwen, Li, Wenli, Fei, Yunyun, Wang, Li, Chen, Yingying, Zeng, Xiaofeng, Zhang, Fengchun, Li, Yongzhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393007/ https://www.ncbi.nlm.nih.gov/pubmed/32793241 http://dx.doi.org/10.3389/fimmu.2020.01619

Ejemplares similares

Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis
por: Li, Wenli, et al.
Publicado: (2021)

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
por: Chiang, Eugene Y, et al.
Publicado: (2022)

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
por: Yeo, Jinah, et al.
Publicado: (2021)

Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy
por: Meggyes, Matyas, et al.
Publicado: (2022)

Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study
por: Bian, Sainan, et al.
Publicado: (2018)

Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis
por: Deng, Chuiwen, et al.
Publicado: (2016)

CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells
por: Yasutomi, Motoko, et al.
Publicado: (2022)

Animal models of primary biliary cholangitis: status and challenges
por: Wang, Xu, et al.
Publicado: (2023)

Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia
por: Szereday, Laszlo, et al.
Publicado: (2021)

The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies
por: Li, Wenli, et al.
Publicado: (2023)

Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
por: Jin, Hyung-seung, et al.
Publicado: (2021)

Meta-analysis of the changes of peripheral blood regulatory T cell to CD4(+) T cell ratio in patients with systemic sclerosis
por: Deng, Chuiwen, et al.
Publicado: (2017)

TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation
por: Worboys, Jonathan D., et al.
Publicado: (2023)

Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4(+) Treg Cells in Patients with Rheumatoid Arthritis
por: Yang, Mengru, et al.
Publicado: (2019)

Perturbed CD8(+) T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
por: Tauriainen, Johanna, et al.
Publicado: (2017)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

The Ratio of CD226 and TIGIT Expression in Tfh and PD-1(+)ICOS(+)Tfh Cells Are Potential Biomarkers for Chronic Antibody-Mediated Rejection in Kidney Transplantation
por: Fan, Ji-wen, et al.
Publicado: (2022)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Plasma lipidomics of primary biliary cholangitis and its comparison with Sjögren’s syndrome
por: Li, Haolong, et al.
Publicado: (2023)

Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals
por: Yin, Xiaowan, et al.
Publicado: (2018)

Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study
por: Deng, Chui-Wen, et al.
Publicado: (2017)

Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
por: Gao, Xiuzhu, et al.
Publicado: (2023)

Expression of the immune checkpoint receptor TIGIT in seminoma
por: Hinsch, Andrea, et al.
Publicado: (2019)

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
por: Li, Chunlei, et al.
Publicado: (2022)

New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage
por: Reshetnyak, Vasiliy Ivanovich, et al.
Publicado: (2023)

Histopathological Diagnostic Value of the IgG4(+)/IgG(+) Ratio of Plasmacytic Infiltration for IgG4-Related Diseases: A PRISMA-Compliant Systematic Review and Meta-Analysis
por: Deng, Chuiwen, et al.
Publicado: (2015)

Update in TIGIT Immune-Checkpoint Role in Cancer
por: Annese, Tiziana, et al.
Publicado: (2022)

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer
por: Maas, Ralph Ja, et al.
Publicado: (2020)

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
por: Li, Wenchao, et al.
Publicado: (2018)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Diagnostic value of the antiglycoprotein-2 antibody for Crohn’s disease: a PRISMA-compliant systematic review and meta-analysis
por: Deng, Chuiwen, et al.
Publicado: (2017)

Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization study
por: Xu, Honglin, et al.
Publicado: (2022)

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)

TIGIT is a key inhibitory checkpoint receptor in lymphoma
por: Godfrey, James, et al.
Publicado: (2023)

TIGIT, a novel immune checkpoint therapy for melanoma
por: Tang, Wei, et al.
Publicado: (2023)

Emperipolesis mediated by CD8(+) T cells correlates with biliary epithelia cell injury in primary biliary cholangitis
por: Zhao, Su‐xian, et al.
Publicado: (2019)

BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer
por: Feng, Mei, et al.
Publicado: (2021)

TIGIT Can Exert Immunosuppressive Effects on CD8(+) T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro
por: Zhang, Changkun, et al.
Publicado: (2020)

Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
por: Yang, Yanlei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1beduanvrmrsrkrv3s2hsbv5ml